Diabetic Hypoglycaemia: ESP Bioscience Announces New Journal For 2008 (01 July 2008)

Main Category: Diabetes
Article Date: 02 Jul 2008 - 4:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

ESP Bioscience today announced the forthcoming launch of Diabetic Hypoglycaemia (www.hypodiab.com), an influential new online diabetes journal delivering a range of hypoglycaemia information, including: background science, human physiology, and clinical and educational communications. Diabetic Hypoglycaemia is created with and run by an editorial board of hypoglycaemia experts led by Professor Brian Frier (Edinburgh, UK) with Associate Editors: Simon Heller (Sheffield, UK), Christopher Ryan (Pittsburgh, US) and Rory McCrimmon (Yale, US). The journal will be published three times per year, providing an interactive forum for readers to share practical knowledge and opinions on the rapidly evolving topic that is hypoglycaemia.

"Diabetic Hypoglycaemia will provide an essential new source of hypoglycaemia awareness for those people in diabetes care and research who have an interest in this important field" commented the journal editors. "Our goal is to create an independent open access online journal advancing hypoglycaemia care and research through information sharing, topical review and expert discussion". Initial support of the journal is provided by an unrestricted educational grant from Novo Nordisk A/S (Bagsvaerd, Denmark).

Please visit the journal website at www.hypodiab.com for a free view of the preview content.

About ESP Bioscience

ESP Bioscience (a division of ESP Limited) is a publisher of novel and new medical information products and online medical communities, with headquarters in Sandhurst, United Kingdom. Working in association with its academic partners in the global healthcare community, ESP Bioscience publishes journals, books and online resources.